You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IL2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer Trial in Houston (Aldesleukin)

Completed
  • Alzheimer Disease
  • Houston, Texas
    Alireza Faridar
Apr 19, 2023

Allergic Rhinoconjunctivitis to Birch Pollen, With a Positive Skin Prick Test to Birch Pollen Trial in Paris (ILT-101 ld-(IL2))

Completed
  • Allergic Rhinoconjunctivitis to Birch Pollen
  • With a Positive Skin Prick Test to Birch Pollen
  • ILT-101 ld-(IL2)
  • Paris, France
    CIC Paris Est GH Pitié Salpétrière
Dec 13, 2022

Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

Not yet recruiting
  • Esophagus Cancer
  • +4 more
  • Intravenous injection of P-IL-2
  • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
  • (no location specified)
Apr 24, 2023

Metastatic Solid Tumor Trial ([18F]AlF-RESCA-IL2 PET scan)

Not yet recruiting
  • Metastatic Solid Tumor
  • [18F]AlF-RESCA-IL2 PET scan
  • (no location specified)
Jul 20, 2022

Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

Not yet recruiting
  • Head and Neck Neoplasms
  • TransCon TLR7/8 Agonist
  • +2 more
  • (no location specified)
Aug 4, 2023

Metastatic Melanoma Trial in Tampa (procedure, drug, other)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Surgery
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023

Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 6, 2022

HIV Infection Trial in Cleveland (Recombinant Interleukin-2)

Terminated
Has Results
  • HIV Infection
  • Recombinant Interleukin-2
  • Cleveland, Ohio
    AIDS Clinical Trials Unit
Sep 1, 2022

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Primary Peritoneal Cavity Cancer Trial in Minneapolis (IP FT516, Enoblituzumab,

Completed
  • Ovarian Cancer
  • +2 more
  • IP FT516
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota, Masonic Cancer Center
Apr 12, 2022

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Metastatic Melanoma Trial in Tampa (drug, procedure, biological)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 8, 2022

Metastatic Melanoma Stage IV Trial in Tuebingen, Siena (L19IL2 - Ph I, L19IL2 at RD - Ph II, DTIC)

Active, not recruiting
  • Metastatic Melanoma Stage IV
  • L19IL2 - Ph I
  • +2 more
  • Tuebingen, Germany
  • +1 more
Apr 13, 2022

Alzheimer Trial in Houston (Interleukin-2, Placebo)

Recruiting
  • Alzheimer Disease
  • Houston, Texas
    Houston Methodist Research Institute
Oct 17, 2023

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Münster (L19-IL2 - Ph I, L19-IL2 at RD - Ph II, Rituximab)

Active, not recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • L19-IL2 - Ph I
  • +2 more
  • Münster, Germany
    Münster University Hospital
Apr 19, 2022

NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma Breast
  • Suzhou, China
    Second Affiliated Hospital of Soochow University
Oct 29, 2022

NSCLC (NSCLC) Trial in Basel (F16IL2, Nivolumab, fixed dose)

Active, not recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Basel, Switzerland
    Basel University Hospital
Jul 19, 2022

Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)

Terminated
  • Neuroblastoma
  • antibody ch14.18
  • +4 more
  • Cologne, Germany
    University of Cologne
Nov 3, 2022

Advanced Solid Tumor, Metastatic Cancer Trial in Miranda, Clayton, Heidelberg (AU-007, Aldesleukin)

Recruiting
  • Advanced Solid Tumor
  • Metastatic Cancer
  • Miranda, New South Wales, Australia
  • +2 more
Jun 10, 2022

Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Proleukin 1.3 MG Injection
  • (no location specified)
Apr 6, 2023

Metastatic Renal Cell Carcinoma Trial in Boston (HD IL2)

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • HD IL2
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jun 20, 2022

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Alzheimer Trial in Paris (Proleukin, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • Paris, France
    GHU Saint Anne
Jul 18, 2022

Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

Recruiting
  • Colorectal Cancer
  • +11 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023

Melanoma Trial in Madison (hu14.18-IL2, Radiation Therapy, Nivolumab)

Suspended
  • Melanoma
  • hu14.18-IL2
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jan 3, 2022